Evidence map›Paper›PMID 36993460›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Symptom-led staging for primary progressive aphasia.

Chris Jd Hardy, Cathleen Taylor-Rubin, Beatrice Taylor, Emma Harding, Aida Suarez Gonzalez, Jessica Jiang, Laura Thompson, Rachel Kingma, Anthipa Chokesuwattanaskul, Ffion Walker and 15 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 11 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 3 countries.

Chris Jd HardyDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Cathleen Taylor-RubinUniting War Memorial Hospital, Sydney, Australia.
Beatrice TaylorCentre for Medical Image Computing, Department of Computer Science, UCL, London, UK.
Emma HardingDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Aida Suarez GonzalezDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Jessica JiangDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Laura ThompsonUniting War Memorial Hospital, Sydney, Australia.
Rachel KingmaUniting War Memorial Hospital, Sydney, Australia.
Anthipa ChokesuwattanaskulDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Ffion WalkerHealthAbility, Melbourne, Australia.
Suzie BarkerDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Emilie BrotherhoodDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Claire WaddingtonDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Olivia WoodDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Nikki ZimmermannDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Nuriye KupeliMarie Curie Palliative Care Research Department, Division of Psychiatry, UCL, London, UK.
Keir Xx YongDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Paul M CamicDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Josh StottDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Charles R MarshallPreventive Neurology Unit, Queen Mary University of London, London, UK.
Neil P OxtobyCentre for Medical Image Computing, Department of Computer Science, UCL, London, UK.
Jonathan D RohrerDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Anna VolkmerDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Sebastian J CrutchDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
Jason D WarrenDementia Research Centre, UCL Queen Square Institute of Neurology, UCL, London, UK.
UK Dementia Research Institute · GBAustralian War Memorial · AUUniversity College London · GBQueen Mary University of London · GBThai Red Cross Society · TH

Funding

Studying crowding as a window into object recognition and development and health of visual cortexR01EY027964 · NEI · NEW YORK UNIVERSITY · PI PELLI, DENIS G · 2018 to 2020
$1.2M
Marie Curie MCCC-FCO-11-UMedical Research Council MR/J009482/1Medical Research Council MR/M008525/1Medical Research Council MR/M023664/1Medical Research Council MR/T046015/1NEI NIH HHS R01 EY027964Wellcome Trust
6 · The paper itself

Abstract

The primary progressive aphasias (PPA) present complex and diverse challenges of diagnosis, management and prognosis. A clinically-informed, syndromic staging system for PPA would take a substantial step toward meeting these challenges. This study addressed this need using detailed, multi-domain mixed-methods symptom surveys of people with lived experience in a large international PPA cohort. We administered structured online surveys to caregivers of patients with a canonical PPA syndromic variant (nonfluent/agrammatic (nvPPA), semantic (svPPA) or logopenic (lvPPA)). In an 'exploratory' survey, a putative list and ordering of verbal communication and nonverbal functioning (nonverbal thinking, conduct and wellbeing, physical) symptoms was administered to 118 caregiver members of the UK national PPA Support Group. Based on feedback, we expanded the symptom list and created six provisional clinical stages for each PPA subtype. In a 'consolidation' survey, these stages were presented to 110 caregiver members of UK and Australian PPA Support Groups, and refined based on quantitative and qualitative feedback. Symptoms were retained if rated as 'present' by a majority (at least 50%) of respondents representing that PPA syndrome, and assigned to a consolidated stage based on majority consensus; the confidence of assignment was estimated for each symptom as the proportion of respondents in agreement with the final staging for that symptom. Qualitative responses were analysed using framework analysis. For each PPA syndrome, six stages ranging from 1 ('Very mild') to 6 ('Profound') were identified; earliest stages were distinguished by syndromic hallmark symptoms of communication dysfunction, with increasing trans-syndromic convergence and dependency for basic activities of daily living at later stages. Spelling errors, hearing changes and nonverbal behavioural features were reported at early stages in all syndromes. As the illness evolved, swallowing and mobility problems were reported earlier in nfvPPA than other syndromes, while difficulty recognising familiar people and household items characterised svPPA and visuospatial symptoms were more prominent in lvPPA. Overall confidence of symptom staging was higher for svPPA than other syndromes. Across syndromes, functional milestones were identified as key deficits that predict the sequence of major daily life impacts and associated management needs. Qualitatively, we identified five major themes encompassing 15 subthemes capturing respondents' experiences of PPA and suggestions for staging implementation. This work introduces a prototypical, symptom-led staging scheme for canonical PPA syndromes: the PPA Progression Planning Aid (PPA

Identifiers

PMID36993460
PMCPMC10055437
OpenAlexW4327862104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.